Advertisement
MarketWatch

A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved

A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

M

Source

MarketWatch

Read full article at MarketWatch

Opens original article in a new tab

Advertisement

Related Economy Stories

Advertisement